Home
University of Bergen
Neuro-SysMed

News archive for Neuro-SysMed

Studien var ledet av professor og overlege Charalampos Tzoulis (midten), sammen med senior forsker Christian Dölle (venstre) og overlege Brage Brakedal (høyre).
Targeting the brain's energy metabolism may hold the key for treating Parkinson’s disease (02.03.2022)
The results of a new clinical trial, published in the peer-reviewed journal Cell Metabolism, show that oral intake of nicotinamide riboside (NR) enhances NAD-metabolism in the brain of individuals with Parkinson’s disease, and shows promise as a potential therapy.